DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/865vlf/medintellibase) has announced the addition of the "MedIntelliBase® Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks")" subscription to their offering.
Medical industry executives who rely on timely business intelligence now have two smarter alternatives - MedIntelliBase Alerts and MedIntelliBase MarketTracks services. Both cloud and mobile, fully searchable services help biotech, medical device and pharmaceutical companies gain and sustain their competitive advantage.
MedIntelliBase gives you customized cloud and mobile intelligence services to satisfy your highly specialized information collection and reporting needs. Highly customized, precisely targeted intelligence on areas of business, finance, regulations, clinical research and medical technology interest are pushed, streamed and accessed as you require.
In particular, MedIntelliBase (MIB) MarketTracks are concise Summaries of Clinical Trials and Product Technologies. All Clinical Trial Summaries are indexed by Company, Principal Investigator (PI) and PI Study Site. All Product Technology Summaries are indexed by Company. The Summaries are updated throughout the month published in final form each month with Summary Update Emails sent to you and RSS Breaking News fed to you.
For the Subject Area ""Lower Limb ""Critical Limb Ischemia (CLI) Therapeutics - MarketTracks: As of January 2015 the Number of Clinical Trials/Registries included = 45; the Number of Product Technologies included = 25; the Number of Companies included = 22. This Subject Area is growing as its authors discover newly announced trials and emerging product technologies.
Key Topics Covered:
1. Arteries
2. Therapeutic Approach
3. Clinical Focus
4. Companies
Companies Mentioned
- Abbott Vascular Devices
- AtheroMed, Inc.
- Bard Peripheral Vascular, Inc. / C. R. Bard
- BIOTRONIK
- Boston Scientific Corporation, Inc.
- Cardiovascular Systems, Inc.
- Cook, Inc.
- Covidien (eV3)
- CryoVascular Systems, Inc. (Boston Scientific Corporation)
- Edwards Lifesciences
- EKOS Corporation
- Guidant Corporation (Abbott Vascular Devices/Boston Scientific Corporation)
- Intact Vascular, Inc.
- Invatec (Medtronic)
- Lutonix, Inc.
- Medtronic (Bayer / MEDRAD Interventional (Possis Medical, Inc.))
- Medtronic Vascular
- Spectranetics Corporation
- TriReme Medical
- Terumo Medical Corporation
- Vascular Solutions, Inc.
For more information visit http://www.researchandmarkets.com/research/865vlf/medintellibase
